The largest database of trusted experimental protocols

Octet system

Manufactured by Molecular Devices
Sourced in United States

The Octet system is a label-free, real-time biomolecular interaction analysis platform. It enables the measurement of kinetics, affinity, and concentration of biomolecular interactions between proteins, peptides, small molecules, and other analytes.

Automatically generated - may contain errors

37 protocols using octet system

1

Biotin-Conjugation and Progesterone Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified proteins were diluted or dialyzed in dialysis buffer (KH2PO4 42 mM, Na2HPO4 8 mM, NaCl 136 mM, KCl 2.6 mM, pH 7.4, Tween 20 0.02%) and biotinylated using the EZ-Link®NHS-PEO4-Biotinylation Kit (Thermo Fisher Scientific, Waltham, MA, USA) for 30 min at room temperature. The unconjugated biotin was removed by Zeba Spin desalting column (Thermo Fisher Scientific, Waltham, MA, USA). The biotin-conjugated protein was diluted to 50 µg/mL. The Super Streptavidin sensors (Fortebio, Silicon Valley, CA, USA) were pre-wetted in dialysis buffer for 15 min prior to use and then loaded with biotinylated proteins for 15 min. The sensors unloaded with biotinylated proteins or loaded with rTrx was used as controls to correct for base-line drift. Progesterone was prepared in serial dilutions (0.125, 0.25, 0.5, 1, 2, and 4 mM) in a 96-well plate. Measurements were carried out automatically at room temperature using the Fortebio’s Octet System and analyzed by Octet System Data Analysis. Every experiment was repeated twice.
+ Open protocol
+ Expand
2

Binding Affinity Measurements of Anti-BTLA Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 4

Binding affinities of anti-BTLA antibodies to human and cynomolgus BTLA were measured by Bio-Layer Interferometry (Octet® systems from FortéBIO). 10 μg/ml of each anti-BTLA antibody was immobilized on the biosensor tip surface via anti-human-Fc (AHC) capture. Human or cynomolgus BTLA was diluted in PBS and loaded at concentrations from 166.7 nM to 6.17 nM in 3-fold serial dilutions. Binding curves were fitted to a 1:1 interaction model using the analysis software provided by the Octet® systems. FIG. 4 shows exemplary association and dissociation curves between anti-BTLA antibody 13-F7A and human BTLA at different concentrations (166.7 nM, 55.6 nM, 18.5 nM and 6.17 nM). Table 7 shows a summary of binding dissociation constant (KD) for different anti-BTLA antibodies to human and cynomolgus BTLA measured by Bio-Layer Interferometry.

TABLE 7
Human BTLACyno BTLA
ClonesKD (nM)KD (nM)
16-I20A14.916.6
15-C19A144.00.1
16-H16A13.94.1
12-I8A25.223.2
8-M23A101.037.3
13-F7A5.43.9
4C714.276.5
comparator

+ Open protocol
+ Expand
3

Measuring TRAIL-Death Receptor Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
Biolayer interferometry performed on Octet systems (Pall Forte Bio LLC, CA) was used to measure the affinity of TRAIL proteins for death receptors. The death receptor proteins DR4-Fc and DR5-Fc (Sino Biological, Beijing, China) were immobilized on a protein A-coated biosensor followed by insertion into solutions containing different concentrations of TRAIL proteins for association according to our previous works (Yang et al., 2018 (link)). In addition, death receptor binding was also measured by neutralizing the cytotoxicity of TRAIL proteins. Briefly, in the cytotoxicity assay system, TRAIL proteins (2.5–50 nM) were mixed with DR4-Fc or DR5-Fc at different molar ratios (DR protein: TRAIL = 0–3) prior to addition to cells. The viabilities of cells treated with TRAIL proteins in the presence or absence of death receptor proteins were measured and compared. The increase in the viability of cancer cells after treatment with TRAIL proteins in the presence of death receptor proteins reflects the binding of TRAIL proteins to death receptors.
+ Open protocol
+ Expand
4

Biolayer Interferometry Analysis of Protein Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Biolayer interferometry performed on Octet® systems (Pall ForteBio LLC, CA) was used to reveal protein-protein interactions. For IgG binding assay, IgG was immobilized on a protein A-coated sensor. Subsequently, the sensor was inserted into a solution containing different concentrations (0-2 μM) of IgBD-TRAIL for 300 s to enable association, followed by disassociation in PBS for 200 s. The association constant ka, disassociation constant kd, and affinity KD (KD=kd/ka) were calculated by using software for Octet® systems according to 1:1 binding model. For death receptor binding assay, DR4-Fc or DR5-Fc (R&D, MN) were captured by a protein A-coated sensor, followed by the insertion of the sensor into solutions containing different concentrations of TRAIL fusion proteins. For albumin binding assays, ABD-TRAIL was captured by using a His-tag antibody-coated sensor, followed by the insertion of the sensor into a series of albumin solutions.
+ Open protocol
+ Expand
5

Lectin-based Glycoprotein Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Relative quantification of N-glycans present on the target-binding domain was performed by lectin-based bio-layer interferometry using OctetSystems (ForteBio). Before the lectin assay, Fc-fusion protein concentrations were determined as described above, followed by sam-
+ Open protocol
+ Expand
6

Affinity Characterization of Humanized Nb1902-Fc

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 7

(1) The humanized single domain antibody Nb1902-Fc was gradient diluted from 100 nM with PBST, respectively: 100 nM, 66.7 nM, 44.4 nM, 29.6 nM, 19.8 nM, 13.2 nM. The antigen proteins hCD47 (ECD)-Fc and Fc were diluted to 30 μg/mL, respectively. (2) Setting the operating conditions of the instrument: temperature 30° C., shake speed 1000 rpm. Using ProteinA-coated probe (Fortebio Part No: 18-5010) to capture antibody for 180s; binding the gradient diluted antigen for 180s; 300s of dissociation time; 10 mM glycine (PH1.7) regeneration 3 times, 5s for each time. (3) Using ForteBio's Octet System for on-board testing.

The test results are shown in FIG. 9: The affinity of humanized Nb1902-Fc is 1.65E-9 M, which is similar to the reported affinity of the control antibody. Reference: Zeng D, Sun Q et al., Oncotarget. 2016 Dec. 13; 7 (50): 83040-83050.

+ Open protocol
+ Expand
7

Measuring Antibody-Antigen Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bio-layer interferometry measurements were performed using anti–human IgG sensors in an Octet system (ForteBio). Anti-αIIbβ3 mAbs (10 μg/mL) were captured on the sensors for 10 minutes. Equilibrium dissociation constants (KD) were determined by monitoring over 85 minutes the association between the immobilized antibodies and αIIbβ3 in solution in duplicate for 7 concentrations of antigen (200, 100, 50, 25, 12.5, 6.25, and 3.13 nM). An irrelevant IgG mAb was used as negative control to subtract the background signal. Data analysis was performed using the Octet Analysis software (ForteBio), and KD values were calculated by steady-state analysis.
+ Open protocol
+ Expand
8

Binding Kinetics of Anti-CD71 Fab

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 23

This Example shows that an anti-human CD71 antigen-binding fragment (Fab) of the present disclosure, which is derived from anti-human CD71 antibody of the present disclosure, demonstrated a binding affinity to recombinant human and cynomolgus CD71 protein.

A Fab antigen-binding fragment was generated by digestion of anti-CD71 21.12 antibody of the present disclosure with the papain enzyme in accordance with known protocols to generate an anti-CD71 Fab fragment. The anti-CD71 Fab fragment of the present disclosure was assayed for binding to recombinant human or cynomolgus CD71 protein by measurement of the kinetic on- and off-rates of a 1:3 dilution series of the Fab fragment to a substrate-immobilized recombinant CD71 protein (Octet system, ForteBio). The recombinant CD71 proteins included a hexa-histidine (His6) peptide tag, by which the protein was immobilized to a Ni-NTA (nitrilotriacetic acid)-containing substrate. The results are shown in Table 19.

TABLE 19
Binding Kinetics of Anti-CD71 Fab
to Human and Cynomolgus CD71
Targetkon (1/Msec)kdis (sec−1)Kd (nM)
Human CD71-His66.64 × 1053.98 × 10−314
Cyno CD71-His63.90 × 1055.59 × 10−36

+ Open protocol
+ Expand
9

Binding Affinity Analysis of SARS-CoV-2 Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Binding studies were carried out using the Octet system (ForteBio, USA, Version 8.1, 2015) that measures biolayer interferometry (BLI) as previously described [18 (link)]. All steps were performed at 30 °C with shaking at 1500 rpm in a black 96-well plate containing 200 μl solution per well. For affinity measurements, streptavidin-coated biosensors were loaded with biotinylated antibodies (5 μg/ml) to reach 1-nm wavelength shift followed by a wash. The sensors were then reacted for 300 s with increasing concentrations of RBD/NTD (association phase) and then transferred to buffer-containing wells for another 600 s (dissociation phase). Binding and dissociation were measured as changes over time in light interference after subtraction of parallel measurements from unloaded biosensors. Sensorgrams were fitted with a 1:1 binding model using the Octet data analysis software 8.1 (Fortebio, USA, 2015), and the presented values are an average of several repeated measurements (at least two repeats). For binning experiments of antibody pairs, antibody-loaded sensors were incubated with a fixed S1 concentration (200 nM), washed and incubated with the non-labeled antibody counterpart. For concomitant binding, antibodies were consecutively loaded on the pre-existing antibody-antigen complex, with no regeneration step.
+ Open protocol
+ Expand
10

DltB-DltC Binding Interaction Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pull down assays were performed as described below. 10 μg of wild-type DltB (or DltB mutants), 20 μg of wild-type GST-DltC (or GST-DltC mutants) and 10 μl GS4B resin were mixed in 100 μl of pull down buffer containing 25 mM HEPES pH 7.5, 150 mM NaCl and 0.15% (w/v) DM. The mixed samples were incubated at 4 °C on a rotisserie for 1 h, followed by washing the resin with pull down buffer for 3 times. During each wash, 100 μl of pull down buffer was added to each sample and incubated at room temperature for 2 min before centrifugation and removal of supernatant. After wash, resin samples were analyzed by SDS-PAGE, with Coomassie Blue staining.
Binding assays were also performed at room temperature using Octet system (FortéBio). Free GST, and GST-tagged WT DltC or DltC mutants were mobilized on anti-GST biosensors (FortéBio). After quenching with free GST to block free antibody sites on biosensors, the biosensors were dipped into DltB solutions for binding measurement. The concentration gradient of DltB used in Octet binding assay is: 0.03 μM, 0.1 μM, 0.3 μM, 1 μM, 3 μM, 10 μM.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!